Sio Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Sio Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-161,285	Closed	-$3.55M	–	72
2022 Q1	$3.55M	Sell	161,285 -109,029	-40%	-$2.22M	1.17%	23
2021 Q4	$4.31M	Buy	270,314 +21,336	+9%	+$332K	1.3%	22
2021 Q3	$4.96M	Sell	248,978 -205,914	-45%	-$3.35M	1.58%	17
2021 Q2	$7.87M	Buy	454,892 +17,754	+4%	+$318K	1.96%	16
2021 Q1	$8.66M	Sell	437,138 -57,605	-12%	-$1.1M	1.76%	20
2020 Q4	$8.64M	Buy	+494,743	New	+$9.73M	1.77%	18
2020 Q2	–	Sell	-10,701	Closed	-$150K	–	86
2020 Q1	$150K	Buy	+10,701	New	+$176K	0.05%	66

Other funds holding MIRM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sio Capital Management's MIRM Position: Q2 2022 in Review

Sio Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2022, closing a stake of 161,285 shares — an estimated $3.55M sold.

Sio Capital Management first reported a position in MIRM in Q1 2020 and held it in 7 quarters. The position peaked at $8.66M in Q1 2021. 109 funds tracked by Wall St. Rank hold MIRM as of Q2 2022.

Sio Capital Management reported no remaining Mirum Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Sio Capital Management sold 161,285 Mirum Pharmaceuticals shares in Q2 2022, an estimated $3.55M.
Sio Capital Management first reported a position in Mirum Pharmaceuticals in Q1 2020 and held it in 7 quarters.
Sio Capital Management's Mirum Pharmaceuticals position peaked at $8.66M in Q1 2021.
109 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2022.

Based on Sio Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.